ammonium hydroxide and rifamycins

ammonium hydroxide has been researched along with rifamycins in 37 studies

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (5.41)	18.7374
1990's	3 (8.11)	18.2507
2000's	4 (10.81)	29.6817
2010's	25 (67.57)	24.3611
2020's	3 (8.11)	2.80

Authors

Authors	Studies
Calzetti, C; Fiaccadori, F; Missale, G; Pedretti, G	1
Celle, G; De Leo, C; Eftimiadi, C; Rovida, S; Schito, GC; Sukkar, GS; Testa, R	1
Pasquini, G	1
Ferrieri, A; Massimetti, A; Puxeddu, A; Quartini, M	1
Ferrieri, A; Miglio, F; Rossellini, SR; Valpiani, D	1
Castells, L; Coll, I; Fernández-Rodríguez, C; Mas, A; Pardo, A; Planas, R; Rodés, J; Rodrigo, L; Rodríguez-Martínez, D; Sunyer, L; Vargas, V	1
Avallone, R; Baraldi, C; Baraldi, M; Corsi, L; Venturini, I; Zeneroli, ML	1
Córdoba Cardona, J; García Martínez, R	1
Shaikh, OS; Sundaram, V	1
Riordan, SM; Williams, R	1
Romero-Gómez, M	1
Mullen, KD; Prakash, R	1
Bajaj, JS; Bell, DE; Fuchs, M; Gibson, DP; Hafeezullah, M; Heuman, DM; Luketic, V; Saeian, K; Sanyal, AJ; Sterling, RK; Stravitz, RT; Wade, JB; Wegelin, JA	1
Bapat, PM; Sinha, A; Wangikar, PP	1
Khungar, V; Poordad, F	2
Fehérvári, I; Gerlei, Z; Görög, D; Kóbori, L; Nemes, B	1
Bartolí, R; Galan, A; Miquel, M; Morillas, R; Odena, G; Planas, R; Serafín, A	1
Häussinger, D; Kircheis, G	1
Lamb, C; Reddy, AV	1
Garcovich, M; Gasbarrini, A; Ponziani, FR; Roccarina, D; Zocco, MA	1
Clough, C; Foxton, MR; Kok, B; Shawcross, DL	1
Jalan, R; Jover-Cobos, M; Khetan, V	1
Hadjihambi, A; Jalan, R; Khetan, V	1
Braddock, M; Chen, YP; Huang, GQ; Huang, S; Lin, YQ; Shi, KQ; Wang, LR; Zheng, MH; Zhu, GQ	1
Utzt, MJ	1
Direkze, S; Jalan, R	1
Sussman, NL	1
Kodali, S; McGuire, BM	1
Petersen, KU	1
Fukui, N; Isobe, M; Okada, M; Saito, T; Suzuki, H; Tamaoki, S	1
Dasarathy, S; Davuluri, G; Deutz, NEP; Engelen, MPKJ; Kumar, A; Prayson, R; Silva, RNE; Ten Have, GAM	1
Akahane, T; Furukawa, M; Kaji, K; Kawaratani, H; Kitade, M; Mitoro, A; Moriya, K; Namisaki, T; Saikawa, S; Sato, S; Takaya, H; Yoshiji, H	1
Bajaj, JS; Biggins, SW; Bissonnette, J; Kamath, PS; Lai, J; Leise, MD; Reuter, B; Rose, CF; Tandon, P; Wade, JB; Walter, K	1
Hayakawa, Y; Higuchi, M; Inada, K; Ishido, S; Izumi, N; Kakegawa, T; Kaneko, S; Kirino, S; Kurosaki, M; Maeyashiki, C; Matsumoto, H; Nakanishi, H; Nobusawa, T; Okamoto, R; Takahashi, Y; Takaura, K; Tamaki, N; Tanaka, S; Tanaka, Y; Tsuchiya, K; Yamashita, K; Yasui, Y	1
Beuers, U; de Wit, K; Gulersonmez, MC; Middendorp, S; Mukha, A; Ramos Pittol, JM; Stigter, ECA; Takkenberg, RB; van Mil, SWC	1
Amodio, P; Shawcross, DL; Thabut, D	1

Reviews

16 review(s) available for ammonium hydroxide and rifamycins

Article	Year
Management of hepatic encephalopathy: role of rifaximin. Chemotherapy, 2005, Volume: 51 Suppl 1 Topics: Ammonia; Animals; Anti-Bacterial Agents; Antidepressive Agents; Bacteria; Benzodiazepines; Clinical Trials as Topic; Hepatic Encephalopathy; Humans; Intestinal Absorption; Intestines; Rifamycins; Rifaximin	2005
[Update on the management of hepatic encephalopathy]. Revista espanola de enfermedades digestivas, 2008, Volume: 100, Issue:10 Topics: Aged; Ammonia; Anti-Bacterial Agents; Antidotes; Clinical Trials as Topic; Dialysis; Flumazenil; GABA Modulators; Hepatic Encephalopathy; Humans; Liver Transplantation; Meta-Analysis as Topic; Neomycin; Protein Synthesis Inhibitors; Rifamycins; Risk Factors	2008
Hepatic encephalopathy: pathophysiology and emerging therapies. The Medical clinics of North America, 2009, Volume: 93, Issue:4 Topics: Ammonia; Anti-Infective Agents; Drug Therapy, Combination; Dyskinesias; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver; Liver Cirrhosis; Liver, Artificial; Manganese; Metronidazole; Neomycin; Neuropsychological Tests; Portasystemic Shunt, Transjugular Intrahepatic; Protein-Energy Malnutrition; Recurrence; Rifamycins; Rifaximin; Trace Elements; Zinc	2009
Pharmacotherapy of hepatic encephalopathy in cirrhosis. Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:8 Topics: Ammonia; Anti-Bacterial Agents; Fluid Therapy; Flumazenil; Hepatic Encephalopathy; Humans; Intestinal Mucosa; Intestines; Liver Cirrhosis; Nutritional Support; Portasystemic Shunt, Surgical; Probiotics; Rifamycins; Rifaximin	2010
Mechanisms, diagnosis and management of hepatic encephalopathy. Nature reviews. Gastroenterology & hepatology, 2010, Volume: 7, Issue:9 Topics: Ammonia; Gastrointestinal Agents; Gastrointestinal Tract; Hepatic Encephalopathy; Humans; Lactulose; Neuropsychological Tests; Rifamycins; Rifaximin	2010
Management of overt hepatic encephalopathy. Clinics in liver disease, 2012, Volume: 16, Issue:1 Topics: Acarbose; Ammonia; Disease Management; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin	2012
[Hepatic encephalopathy and liver transplantation]. Magyar sebeszet, 2012, Volume: 65, Issue:2 Topics: Ammonia; Anti-Infective Agents; Colon; Dipeptides; Disaccharides; End Stage Liver Disease; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hungary; Hydrogen-Ion Concentration; Lactobacillus; Lactulose; Laxatives; Liver Cirrhosis; Liver Transplantation; Metronidazole; Neomycin; Rifamycins; Rifaximin; Severity of Illness Index; Sugar Alcohols; Systemic Inflammatory Response Syndrome; Treatment Outcome	2012
Hepatic encephalopathy. Clinics in liver disease, 2012, Volume: 16, Issue:2 Topics: Ammonia; Anti-Bacterial Agents; Antidotes; Charcoal; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Prebiotics; Probiotics; Rifamycins; Rifaximin	2012
[Hepatic encephalopathy]. Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:31-32 Topics: Amino Acids, Branched-Chain; Ammonia; Anti-Inflammatory Agents, Non-Steroidal; Astrocytes; Automobile Driving; Brain; Diet, Protein-Restricted; Disability Evaluation; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Ibuprofen; Indomethacin; Lactulose; Nerve Net; Neuroglia; Neurologic Examination; Neuronal Plasticity; Neuropsychological Tests; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Probiotics; Prognosis; Rifamycins; Rifaximin	2012
Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota. World journal of gastroenterology, 2012, Dec-14, Volume: 18, Issue:46 Topics: Ammonia; Anti-Bacterial Agents; Clinical Trials as Topic; Gastroenterology; Hepatic Encephalopathy; Humans; Inflammation; Intestines; Liver; Liver Cirrhosis; Microbiota; Rifamycins; Rifaximin	2012
Treatment of hyperammonemia in liver failure. Current opinion in clinical nutrition and metabolic care, 2014, Volume: 17, Issue:1 Topics: Ammonia; Brain; Glycerol; Hepatic Encephalopathy; Humans; Hyperammonemia; Lactulose; Phenylbutyrates; Probiotics; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin	2014
Pharmacotherapy for hyperammonemia. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:12 Topics: Ammonia; Animals; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hyperammonemia; Lactulose; Rifamycins; Rifaximin; Sorption Detoxification	2014
Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy. Alimentary pharmacology & therapeutics, 2015, Volume: 41, Issue:7 Topics: Amino Acids, Branched-Chain; Ammonia; Dipeptides; Disaccharides; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Mental Health; Neomycin; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin	2015
Diagnosis and Treatment of Low-Grade Hepatic Encephalopathy. Digestive diseases (Basel, Switzerland), 2015, Volume: 33, Issue:4 Topics: Accidental Falls; Ammonia; Carnitine; Cognition Disorders; Electroencephalography; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Laxatives; Liver Cirrhosis; Phenylbutyrates; Psychometrics; Rifamycins; Rifaximin	2015
Treatment of Overt Hepatic Encephalopathy. Clinics in liver disease, 2015, Volume: 19, Issue:3 Topics: Amino Acids, Branched-Chain; Ammonia; Arteriovenous Fistula; Dipeptides; Gastrointestinal Agents; Glycerol; Hepatic Encephalopathy; Humans; Lactulose; Liver Failure; Malnutrition; Ornithine; Phenylbutyrates; Probiotics; Rifamycins; Rifaximin	2015
Diagnosis and Management of Hepatic Encephalopathy in Fulminant Hepatic Failure. Clinics in liver disease, 2015, Volume: 19, Issue:3 Topics: Acetylcysteine; Ammonia; Brain Edema; Free Radical Scavengers; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Intracranial Pressure; Lactulose; Liver Failure, Acute; Neuroimaging; Neuropsychological Tests; Nutritional Support; Rifamycins; Rifaximin	2015

Trials

5 trial(s) available for ammonium hydroxide and rifamycins

Article	Year
Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial. The Italian journal of gastroenterology, 1991, Volume: 23, Issue:4 Topics: Aged; Ammonia; Chronic Disease; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin; Prospective Studies; Rifamycins; Rifaximin	1991
Rifaximin in the treatment of chronic hepatic encephalopathy. Current medical research and opinion, 1995, Volume: 13, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Ammonia; Analysis of Variance; Anti-Bacterial Agents; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Rifamycins; Rifaximin; Time Factors; Treatment Outcome	1995
Rifaximin, a non-absorbable rifamycin, for the treatment of hepatic encephalopathy. A double-blind, randomised trial. Current medical research and opinion, 1997, Volume: 13, Issue:10 Topics: Administration, Oral; Adult; Aged; Ammonia; Anti-Bacterial Agents; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Intestinal Absorption; Male; Middle Aged; Neomycin; Neuropsychological Tests; Rifamycins; Rifaximin	1997
Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial. Journal of hepatology, 2003, Volume: 38, Issue:1 Topics: Acute Disease; Ammonia; Anti-Infective Agents; Double-Blind Method; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Male; Middle Aged; Recurrence; Rifamycins; Rifaximin; Severity of Illness Index; Sugar Alcohols; Treatment Outcome	2003
Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology, 2011, Volume: 140, Issue:2 Topics: Ammonia; Anti-Infective Agents; Automobile Driving; Cognition; Cytokines; Hepatic Encephalopathy; Humans; Middle Aged; Patient Compliance; Quality of Life; Rifamycins; Rifaximin; Severity of Illness Index; Treatment Outcome	2011

Other Studies

16 other study(ies) available for ammonium hydroxide and rifamycins

Article	Year
A non-absorbable rifamycin for treatment of hepatic encephalopathy. Drugs under experimental and clinical research, 1985, Volume: 11, Issue:6 Topics: Absorption; Adult; Aged; Ammonia; Colon; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Paromomycin; Rifamycins; Rifaximin	1985
[Topical therapy of facial burns]. Minerva chirurgica, 1983, Mar-31, Volume: 38, Issue:6 Topics: Administration, Topical; Ammonia; Burns; Facial Injuries; Humans; Rifamycins	1983
Gut flora and hepatic encephalopathy in patients with cirrhosis. The New England journal of medicine, 2010, Mar-25, Volume: 362, Issue:12 Topics: Ammonia; Anti-Infective Agents; Gastrointestinal Agents; Gastrointestinal Tract; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Rifamycins; Rifaximin; Secondary Prevention	2010
Role of extracellular protease in nitrogen substrate management during antibiotic fermentation: a process model and experimental validation. Applied microbiology and biotechnology, 2011, Volume: 91, Issue:4 Topics: Actinomycetales; Ammonia; Anti-Bacterial Agents; Biotechnology; Fermentation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Nitrogen; Peptide Hydrolases; Rifamycins; Time Factors	2011
Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats. World journal of gastroenterology, 2012, May-07, Volume: 18, Issue:17 Topics: Ammonia; Animals; Bacteria; Body Weight; Brain; Brain Edema; Cecum; Endotoxins; Insulin-Like Growth Factor I; Liver Cirrhosis, Experimental; Male; Rats; Rats, Sprague-Dawley; Rifamycins; Rifaximin	2012
Rifaximin may have a dramatic effect on hepatic encephalopathy. Clinical medicine (London, England), 2012, Volume: 12, Issue:5 Topics: Aged; Ammonia; Hepatic Encephalopathy; Humans; Male; Portasystemic Shunt, Transjugular Intrahepatic; Rifamycins; Rifaximin	2012
Rifaximin is an efficacious treatment for the Parkinsonian phenotype of hepatic encephalopathy. Hepatology (Baltimore, Md.), 2013, Volume: 58, Issue:4 Topics: Aged; Ammonia; Anti-Infective Agents; Brain; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinsonian Disorders; Phenotype; Rifamycins; Rifaximin; Treatment Outcome	2013
[In Process Citation]. MMW Fortschritte der Medizin, 2015, Volume: 157 Suppl 2 Topics: Ammonia; Clinical Trials as Topic; Dipeptides; Early Diagnosis; Early Medical Intervention; Evidence-Based Medicine; Hepatic Encephalopathy; Humans; Lactulose; Prognosis; Rifamycins; Rifaximin	2015
[Options in the treatment of hepatic encephalopathy]. Medizinische Monatsschrift fur Pharmazeuten, 2015, Volume: 38, Issue:5 Topics: Amino Acids, Branched-Chain; Ammonia; Anti-Bacterial Agents; Dipeptides; Hepatic Encephalopathy; Humans; Rifamycins; Rifaximin	2015
Development of an experimental rat model of hyperammonemic encephalopathy and evaluation of the effects of rifaximin. European journal of pharmacology, 2016, May-15, Volume: 779 Topics: Ammonia; Animals; Behavior, Animal; Brain; Coma; Disease Models, Animal; Hepatic Encephalopathy; Hyperammonemia; Male; Organ Size; Rats; Rats, Sprague-Dawley; Rifamycins; Rifaximin	2016
Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis. Hepatology (Baltimore, Md.), 2017, Volume: 65, Issue:6 Topics: Ammonia; Analysis of Variance; Animals; Autophagy; Disease Models, Animal; Homeostasis; Hyperammonemia; Injections, Intraperitoneal; Liver Cirrhosis; Male; Muscle Proteins; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Recovery of Function; Rifamycins; Rifaximin; Sarcopenia	2017
Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity. World journal of gastroenterology, 2017, Dec-21, Volume: 23, Issue:47 Topics: Aged; Aged, 80 and over; Ammonia; Anti-Bacterial Agents; Case-Control Studies; Cognition; Endotoxemia; Endotoxins; Feces; Female; Gastrointestinal Microbiome; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Rifamycins; Rifaximin; Treatment Outcome	2017
Assessment of the spectrum of hepatic encephalopathy: A multicenter study. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2018, Volume: 24, Issue:5 Topics: Ammonia; Biomarkers; Canada; Clinical Competence; Cognition; Diet, Protein-Restricted; Education, Medical, Graduate; Gastroenterologists; Gastroenterology; Health Care Surveys; Hepatic Encephalopathy; Humans; Liver Function Tests; Neuropsychological Tests; Nurse Practitioners; Patient Simulation; Physician Assistants; Practice Patterns, Nurses'; Practice Patterns, Physicians'; Predictive Value of Tests; Rifamycins; Rifaximin; Risk Factors; Severity of Illness Index; United States; Video Recording	2018
Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy. Internal medicine (Tokyo, Japan), 2023, Apr-01, Volume: 62, Issue:7 Topics: Ammonia; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Rifamycins; Rifaximin	2023
Rifaximin stimulates nitrogen detoxification by PXR-independent mechanisms in human small intestinal organoids. Liver international : official journal of the International Association for the Study of the Liver, 2023, Volume: 43, Issue:3 Topics: Amino Acids; Ammonia; Hepatic Encephalopathy; Humans; Pregnane X Receptor; Receptors, Steroid; Rifamycins; Rifaximin	2023
Ammonia - an enduring foe - What evaluating whole body ammonia metabolism can teach us about cirrhosis and therapies treating hepatic encephalopathy. Journal of hepatology, 2023, Volume: 79, Issue:2 Topics: Ammonia; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Rifamycins; Rifaximin	2023